U.S. FDA grants Priority Review to simeprevir for combination treatment of genotype 1 chronic hepatitis C
13 May 2013 | By Johnson & Johnson
The U.S. FDA has granted Priority Review to the NDA for simeprevir (TMC435)...
List view / Grid view
News
FDA accepts Biogen Idec’s BLA for first long-lasting factor VIII therapy for hemophilia A
13 May 2013 | By Biogen Idec
The U.S. FDA has accepted BLA for the marketing approval of ELOCTATE™...
BREO™ ELLIPTA™ gains US approval for the treatment of COPD
10 May 2013 | By GlaxoSmithKline
GlaxoSmithKline and Theravance announced that the US FDA has approved BREO™ ELLIPTA™...
Novartis drug Ilaris® approved by FDA
10 May 2013 | By Novartis
Novartis announced that the US Food and Drug Administration (FDA) has approved Ilaris® (canakinumab)...
GSK and Save the Children form unique partnership to save the lives of one million children
9 May 2013 | By GlaxoSmithKline
Working together to accelerate the availability of two children’s medicines...
Abbott announces CE Mark for test to aid doctors with diagnosing and monitoring diabetes
Abbott today announced CE Marking (Conformité Européenne) for the ARCHITECT clinical chemistry Hemoglobin A1c (HbA1c) test, which may aid physicians in diagnosing and monitoring diabetes as well as identifying patients at risk for developing diabetes.
Amgen and Zhejiang Beta Pharma announce planned joint venture in China
9 May 2013 | By Amgen
Goal is to bring Amgen's Vectibix® (panitumumab) to chinese patients...
GSK enters new commitment with the GAVI Alliance to supply cervical cancer vaccine for girls in the world’s poorest countries
9 May 2013 | By GlaxoSmithKline
GSK's new commitment to the GAVI Alliance...
Teva and Alexza announce Teva’s license to market ADASUVE® in the U.S.
8 May 2013 | By TEVA
Teva and Alexza have entered into an exclusive U.S. license and supply agreement...
Real-world data at ARVO highlight transformational outcomes seen with Lucentis®, including lower injection frequency than in original clinical trials
8 May 2013 | By Novartis
"Lucentis was designed to save sight..."
B&W Tek completes series of educational videos
7 May 2013 | By B&W Tek
B&W Tek is pleased to announce the completion of its first series of educational videos...
Avacta systems dramatically save time on formulation studies in Korea
7 May 2013 | By kdm communications limited
Scientists at the specialised biotech company PharmAbcine are completing formulation and stability studies in a fraction of the time...
Amgen announces top-line results of Vectibix® (panitumumab)
7 May 2013 | By Amgen
Study meets primary endpoint of non-inferiority in monotherapy setting...
Novo Nordisk invests DKK 380 million in its Kalundborg plant
6 May 2013 | By Novo Nordisk
Novo Nordisk is investing an additional 380 million Danish kroner in its Kalundborg plant in Denmark...
Bristol-Myers Squibb and Pfizer announce publication of ARISTOTLE subanalysis in circulation
6 May 2013 | By Bristol-Myers Squibb Company
ARISTOTLE studied Eliquis vs. warfarin...
